Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure

Jason S. Hahn, Rod D. Braun, Mark W. Dewhirst, Siqing Shan, Stacey A. Snyder, Janis M Taube, Edgardo T. Ong, Gary Rosner, Richard K. Dodge, Joseph Bonaventura, Celia Bonaventura, Joseph Deangelo, Robert E. Meyer

Research output: Contribution to journalArticle

Abstract

We examined the effect of a nitric oxide (NO) quencher, stroma-free human hemoglobin A (HbA0; 0.01, 0.05, 0.1, 0.2 g/kg), on the blood flow measured using the Doppler flow technique, tumor oxygen pressure (pO2) and the diameter of the arterioles using R3230Ac mammary adenocarcinoma as the tumor model. In female Fischer 344 rats with 1-cm-diameter tumors implanted in the lateral aspect of the left quadriceps, intravenous infusion of 0.1 and 0.2 g/kg HbA0 decreased both central tumor and peripheral tumor blood flow by 20-30% (P <0.05). Tumor pO2 decreased 28% with 0.2 g/kg HbA0, from 15 mm Hg (baseline) to 11 mm Hg at 10 min (P = 0.02). Although 0.2 g/kg HbA0 increased blood flow 55% in the left quadriceps muscle proximal to the implanted tumor (P <0.051, HbA0 had little effect on blood flow in right quadriceps muscle with no tumor implanted, and increased right quadriceps pO2, from 21 mm Hg (baseline) to 23 mm Hg at 10 min (P = 0.03). HbA0 increased mean arterial pressure 5-10% in a manner that was dependent on dose while heart rate concurrently decreased 9-19%. The diameter of the arterioles supplying the tumor was rapidly reduced 10% by 0.2 g/kg HbA0 (P = 0.037) and remained stable through 60 min of observation (P = 0.005). HbA0 selectively reduces tumor blood flow and tumor pO2 through vasoconstriction of the arterioles supplying the tumor. Vascular NO quenching provides an alternative to NO synthase inhibition as a means to achieve the goal of selective tumor hypoxia.

Original languageEnglish (US)
Pages (from-to)185-194
Number of pages10
JournalRadiation Research
Volume147
Issue number2
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Hemoglobin A
Partial Pressure
hemoglobin
blood flow
adenocarcinoma
rats
breasts
partial pressure
Adenocarcinoma
Breast
tumors
Oxygen
oxygen
neoplasms
Neoplasms
arterioles
Arterioles
nitric oxide
Quadriceps Muscle
supplying

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Radiology Nuclear Medicine and imaging
  • Biophysics
  • Radiation

Cite this

Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure. / Hahn, Jason S.; Braun, Rod D.; Dewhirst, Mark W.; Shan, Siqing; Snyder, Stacey A.; Taube, Janis M; Ong, Edgardo T.; Rosner, Gary; Dodge, Richard K.; Bonaventura, Joseph; Bonaventura, Celia; Deangelo, Joseph; Meyer, Robert E.

In: Radiation Research, Vol. 147, No. 2, 1997, p. 185-194.

Research output: Contribution to journalArticle

Hahn, JS, Braun, RD, Dewhirst, MW, Shan, S, Snyder, SA, Taube, JM, Ong, ET, Rosner, G, Dodge, RK, Bonaventura, J, Bonaventura, C, Deangelo, J & Meyer, RE 1997, 'Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure', Radiation Research, vol. 147, no. 2, pp. 185-194. https://doi.org/10.2307/3579420
Hahn, Jason S. ; Braun, Rod D. ; Dewhirst, Mark W. ; Shan, Siqing ; Snyder, Stacey A. ; Taube, Janis M ; Ong, Edgardo T. ; Rosner, Gary ; Dodge, Richard K. ; Bonaventura, Joseph ; Bonaventura, Celia ; Deangelo, Joseph ; Meyer, Robert E. / Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure. In: Radiation Research. 1997 ; Vol. 147, No. 2. pp. 185-194.
@article{65567d7e71e849febe9fb190e6ef0cd2,
title = "Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure",
abstract = "We examined the effect of a nitric oxide (NO) quencher, stroma-free human hemoglobin A (HbA0; 0.01, 0.05, 0.1, 0.2 g/kg), on the blood flow measured using the Doppler flow technique, tumor oxygen pressure (pO2) and the diameter of the arterioles using R3230Ac mammary adenocarcinoma as the tumor model. In female Fischer 344 rats with 1-cm-diameter tumors implanted in the lateral aspect of the left quadriceps, intravenous infusion of 0.1 and 0.2 g/kg HbA0 decreased both central tumor and peripheral tumor blood flow by 20-30{\%} (P <0.05). Tumor pO2 decreased 28{\%} with 0.2 g/kg HbA0, from 15 mm Hg (baseline) to 11 mm Hg at 10 min (P = 0.02). Although 0.2 g/kg HbA0 increased blood flow 55{\%} in the left quadriceps muscle proximal to the implanted tumor (P <0.051, HbA0 had little effect on blood flow in right quadriceps muscle with no tumor implanted, and increased right quadriceps pO2, from 21 mm Hg (baseline) to 23 mm Hg at 10 min (P = 0.03). HbA0 increased mean arterial pressure 5-10{\%} in a manner that was dependent on dose while heart rate concurrently decreased 9-19{\%}. The diameter of the arterioles supplying the tumor was rapidly reduced 10{\%} by 0.2 g/kg HbA0 (P = 0.037) and remained stable through 60 min of observation (P = 0.005). HbA0 selectively reduces tumor blood flow and tumor pO2 through vasoconstriction of the arterioles supplying the tumor. Vascular NO quenching provides an alternative to NO synthase inhibition as a means to achieve the goal of selective tumor hypoxia.",
author = "Hahn, {Jason S.} and Braun, {Rod D.} and Dewhirst, {Mark W.} and Siqing Shan and Snyder, {Stacey A.} and Taube, {Janis M} and Ong, {Edgardo T.} and Gary Rosner and Dodge, {Richard K.} and Joseph Bonaventura and Celia Bonaventura and Joseph Deangelo and Meyer, {Robert E.}",
year = "1997",
doi = "10.2307/3579420",
language = "English (US)",
volume = "147",
pages = "185--194",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "2",

}

TY - JOUR

T1 - Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure

AU - Hahn, Jason S.

AU - Braun, Rod D.

AU - Dewhirst, Mark W.

AU - Shan, Siqing

AU - Snyder, Stacey A.

AU - Taube, Janis M

AU - Ong, Edgardo T.

AU - Rosner, Gary

AU - Dodge, Richard K.

AU - Bonaventura, Joseph

AU - Bonaventura, Celia

AU - Deangelo, Joseph

AU - Meyer, Robert E.

PY - 1997

Y1 - 1997

N2 - We examined the effect of a nitric oxide (NO) quencher, stroma-free human hemoglobin A (HbA0; 0.01, 0.05, 0.1, 0.2 g/kg), on the blood flow measured using the Doppler flow technique, tumor oxygen pressure (pO2) and the diameter of the arterioles using R3230Ac mammary adenocarcinoma as the tumor model. In female Fischer 344 rats with 1-cm-diameter tumors implanted in the lateral aspect of the left quadriceps, intravenous infusion of 0.1 and 0.2 g/kg HbA0 decreased both central tumor and peripheral tumor blood flow by 20-30% (P <0.05). Tumor pO2 decreased 28% with 0.2 g/kg HbA0, from 15 mm Hg (baseline) to 11 mm Hg at 10 min (P = 0.02). Although 0.2 g/kg HbA0 increased blood flow 55% in the left quadriceps muscle proximal to the implanted tumor (P <0.051, HbA0 had little effect on blood flow in right quadriceps muscle with no tumor implanted, and increased right quadriceps pO2, from 21 mm Hg (baseline) to 23 mm Hg at 10 min (P = 0.03). HbA0 increased mean arterial pressure 5-10% in a manner that was dependent on dose while heart rate concurrently decreased 9-19%. The diameter of the arterioles supplying the tumor was rapidly reduced 10% by 0.2 g/kg HbA0 (P = 0.037) and remained stable through 60 min of observation (P = 0.005). HbA0 selectively reduces tumor blood flow and tumor pO2 through vasoconstriction of the arterioles supplying the tumor. Vascular NO quenching provides an alternative to NO synthase inhibition as a means to achieve the goal of selective tumor hypoxia.

AB - We examined the effect of a nitric oxide (NO) quencher, stroma-free human hemoglobin A (HbA0; 0.01, 0.05, 0.1, 0.2 g/kg), on the blood flow measured using the Doppler flow technique, tumor oxygen pressure (pO2) and the diameter of the arterioles using R3230Ac mammary adenocarcinoma as the tumor model. In female Fischer 344 rats with 1-cm-diameter tumors implanted in the lateral aspect of the left quadriceps, intravenous infusion of 0.1 and 0.2 g/kg HbA0 decreased both central tumor and peripheral tumor blood flow by 20-30% (P <0.05). Tumor pO2 decreased 28% with 0.2 g/kg HbA0, from 15 mm Hg (baseline) to 11 mm Hg at 10 min (P = 0.02). Although 0.2 g/kg HbA0 increased blood flow 55% in the left quadriceps muscle proximal to the implanted tumor (P <0.051, HbA0 had little effect on blood flow in right quadriceps muscle with no tumor implanted, and increased right quadriceps pO2, from 21 mm Hg (baseline) to 23 mm Hg at 10 min (P = 0.03). HbA0 increased mean arterial pressure 5-10% in a manner that was dependent on dose while heart rate concurrently decreased 9-19%. The diameter of the arterioles supplying the tumor was rapidly reduced 10% by 0.2 g/kg HbA0 (P = 0.037) and remained stable through 60 min of observation (P = 0.005). HbA0 selectively reduces tumor blood flow and tumor pO2 through vasoconstriction of the arterioles supplying the tumor. Vascular NO quenching provides an alternative to NO synthase inhibition as a means to achieve the goal of selective tumor hypoxia.

UR - http://www.scopus.com/inward/record.url?scp=0031046621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031046621&partnerID=8YFLogxK

U2 - 10.2307/3579420

DO - 10.2307/3579420

M3 - Article

C2 - 9008211

AN - SCOPUS:0031046621

VL - 147

SP - 185

EP - 194

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 2

ER -